Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BVS
BIOVENTUS INC.
NASDAQ
$13.84
▲ UP 0.36% (0.05)

KEY STATISTICS

Market Cap$937.63 M
52w High$15.89
52w Low$6.25
Dividend Yield—
Frequency—
P/E18.21
Volume445.69K
Shares Out.67.75M

COMPANY

LEADERSHIP

Robert E. Claypoole
CHIEF EXECUTIVE
Robert E. Claypoole

COMPENSATION 2026

Salary$824,110
Stock Awards$1,982,530
Incentive Plan Pay$781,256
All Other Comp.$48,263
Total$4,299,108

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 11, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
950

PRICE TARGET

Target High$19.00
Target Low$18.00
Target Median$18.00
Target Consensus$18.33

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$149.51M
NOV
3
TUE

PRICE

$13.84 ▲ UP 0.36% (+$0.05)
$13.72$13.80$13.87$13.959:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM13.84

About Bioventus Inc.

http://www.bioventus.com ↗

Bioventus Inc. develops and commercializes medical devices and treatments that promote natural healing, including pain management, surgical solutions, and restorative therapies for orthopedic and wound care globally.

INDUSTRY

Medical - Devices

A PRODUCT BIOVENTUS INC. IS KNOWN FOR

BoneScalpel Access
BoneScalpel Access

Bioventus's ultrasonic bone cutting system enables precise, safe minimally invasive spine surgery, forming a key part of their Surgical Solutions portfolio for the growing minimally invasive spine market.

COMPETITORS

COMPETITOR
GMED COMPARE
MDT COMPARE
OFIX COMPARE
SYK COMPARE
ZBH COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
US Segment$123.31M $139.49M ▲$116.44M ▼$134.47M ▲
International Segment$15.34M $18.41M ▲$15.64M ▼$18.74M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$123.31M $139.49M ▲$116.44M ▼$134.47M ▲
NonUS$15.34M $18.41M ▲$15.64M ▼$18.74M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
81
LISTED HERE
22
RANKED BY POSITION SIZE
AVUV
0.07% · 1.5M
IWM
0.02% · 1.2M
VTS.AX
0.00% · 1.2M
FESM
0.07% · 350.1K
SCHA
0.01% · 224.3K
DFMC
0.04% · 211.2K
XHE
0.85% · 111.5K
PSC
0.05% · 100.1K
SFLO
0.14% · 78.7K
EES
0.10% · 51.8K
XRS2.DE
0.02% · 44.1K
HAPS
0.25% · 31.6K
GSSC
0.04% · 30.1K
RSSL
0.02% · 22.9K
SAWS
2.31% · 13.0K
SQLV
0.36% · 10.8K
SYZ
0.16% · 7.7K
EB
EBI
0.01% · 7.5K
IVSS
0.13% · 2.6K
URTY
0.01% · 2.0K
RESM
0.03% · 135
SC0K.DE
0.02% · 0

INSTITUTIONAL OWNERSHIP

SHARES OWNED
63.69%
HOLDERS
213
TOP 12 OF 213 · RANKED BY POSITION SIZE
Essex Woodlands Management, Inc.
13.0M sh · $87.11M
Juniper Investment Company, LLC
6.9M sh · $51.63M
Nantahala Capital Management, LLC
6.1M sh · $55.9M
Blackrock, Inc.
3.4M sh · $32.44M
Vanguard Group Inc
3.0M sh · $22.21M
Blackrock Inc.
2.4M sh · $13.64M
Royce & Associates LP
1.8M sh · $17.31M
Sv Health Investors, LLC
1.5M sh · $10.42M
Geode Capital Management, LLC
1.4M sh · $12.89M
American Century Companies Inc
1.4M sh · $12.78M
Dimensional Fund Advisors LP
1.1M sh · $10.65M
State Street Corp
1.1M sh · $10.43M

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book2
Overall Score4

INSIDER TRADES

★
DIRECTOR
NEELS GUIDO J
Purchase · 25.1K shares
2026-06-03
★
DIRECTOR
McMurry-Heath Michelle
Purchase · 25.1K shares
2026-06-03
★
DIRECTOR
STALNECKER SUSAN M
Purchase · 25.1K shares
2026-06-03
★
DIRECTOR
STALNECKER SUSAN M
Sale · 32.3K shares
2026-06-02

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
OVERWEIGHT 1
OUTPERFORM 1
4 GRADES IN THE LAST 12 MONTHS
Canaccord Genuity BUY Cantor Fitzgerald OVERWEIGHT Barrington Research OUTPERFORM Craig-Hallum BUY

SECTORS PEERS

PEERPRICE
BFLY$8.43COMPARE
CBLL$23.73COMPARE
VREX$18.50COMPARE
KIDS$23.65COMPARE
CTKB$4.68COMPARE
TMCI$4.65COMPARE
LAB$0.64COMPARE